Total Payments
$1,222
2022 Payments
$94.83
Companies
13
Transactions
116
Medicare Patients
13,215
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$1,124 (91.9%)
Education$98.41 (8.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,124 | 114 | 91.9% |
| Education | $98.41 | 2 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $549.92 | 80 | $0 (2019) |
| Astellas Pharma US Inc | $256.42 | 12 | $0 (2019) |
| Janssen Biotech, Inc. | $67.08 | 5 | $0 (2019) |
| UROVANT SCIENCES INC | $55.04 | 3 | $0 (2022) |
| Boston Scientific Corporation | $49.77 | 3 | $0 (2022) |
| COLOPLAST CORP | $49.39 | 3 | $0 (2021) |
| C. R. BARD, INC. & SUBSIDIARIES | $41.63 | 1 | $0 (2019) |
| ABBVIE INC. | $41.34 | 2 | $0 (2022) |
| MEDIVATION INC. | $37.63 | 2 | $0 (2017) |
| 180 Medical, Inc. | $27.56 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $94.83 | 5 | ABBVIE INC. ($41.34) |
| 2021 | $73.64 | 4 | COLOPLAST CORP ($35.42) |
| 2020 | $15.74 | 1 | 180 Medical, Inc. ($15.74) |
| 2019 | $274.74 | 23 | PFIZER INC. ($111.90) |
| 2018 | $292.58 | 39 | PFIZER INC. ($215.48) |
| 2017 | $470.46 | 44 | PFIZER INC. ($222.54) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/10/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/28/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $27.50 | General |
| Category: Urology | ||||||
| 03/02/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $11.88 | General |
| Category: Urology | ||||||
| 01/13/2022 | Boston Scientific Corporation | General - Vascular Access (Device) | Food and Beverage | Cash or cash equivalent | $14.11 | General |
| Category: PROSTATE HEALTH | ||||||
| 11/17/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: HORMONE THERAPY | ||||||
| 11/03/2021 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Continence Care | ||||||
| 10/16/2021 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $15.66 | General |
| Category: Urology | ||||||
| 10/05/2021 | COLOPLAST CORP | Vortek (Device) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Endourology | ||||||
| 01/14/2020 | 180 Medical, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.74 | General |
| 12/12/2019 | Boston Scientific Corporation | REZUM (Device) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: PROSTATE HEALTH | ||||||
| 09/26/2019 | Boston Scientific Corporation | REZUM (Device) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: PROSTATE HEALTH | ||||||
| 09/18/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $8.42 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2019 | ROCHESTER MEDICAL CORPORATION | — | Food and Beverage | In-kind items and services | $14.10 | General |
| 08/13/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Oncology | ||||||
| 07/23/2019 | Coloplast Corp | SPEEDICATH (Device) | Food and Beverage | Cash or cash equivalent | $13.97 | General |
| Category: CONTINENCE | ||||||
| 07/02/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: UROLOGY | ||||||
| 06/26/2019 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 06/17/2019 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 05/28/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Oncology | ||||||
| 05/20/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: ONCOLOGY | ||||||
| 04/22/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: ONCOLOGY | ||||||
| 04/08/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: ONCOLOGY | ||||||
| 03/27/2019 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 37 | 3,731 | 7,812 | $709,853 | $333,349 |
| 2021 | 41 | 4,642 | 8,707 | $1.1M | $394,894 |
| 2020 | 41 | 4,842 | 9,919 | $1.2M | $452,817 |
Total Patients
13,215
Total Services
26,438
Medicare Billing
$1.2M
Procedure Codes
119
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 154 | 2,172 | $79,462 | $75,245 | 94.7% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2022 | 116 | 507 | $38,942 | $35,412 | 90.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 23 | 186 | $107,880 | $25,751 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 242 | $53,240 | $21,075 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 295 | 321 | $48,150 | $18,795 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 127 | 127 | $42,545 | $14,960 | 35.2% |
| 87492 | Detection test by nucleic acid for chlamydia trachomatis, quantification | Office | 2022 | 154 | 249 | $14,171 | $13,183 | 93.0% |
| 87799 | Detection test by nucleic acid for organism, quantification | Office | 2022 | 104 | 290 | $13,805 | $12,382 | 89.7% |
| 87592 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), quantification | Office | 2022 | 154 | 249 | $11,358 | $10,562 | 93.0% |
| 87652 | Detection test by nucleic acid for strep (streptococcus, group a), quantification | Office | 2022 | 154 | 249 | $11,074 | $10,295 | 93.0% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2022 | 154 | 251 | $9,366 | $8,721 | 93.1% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2022 | 152 | 244 | $9,121 | $8,478 | 93.0% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2022 | 149 | 244 | $9,121 | $8,476 | 92.9% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2022 | 149 | 244 | $9,121 | $8,476 | 92.9% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2022 | 149 | 244 | $9,121 | $8,476 | 92.9% |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | Office | 2022 | 149 | 244 | $9,121 | $8,476 | 92.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 112 | 143 | $59,345 | $8,159 | 13.7% |
| 52353 | Crushing of stone of ureter using an endoscope | Facility | 2022 | 16 | 17 | $13,685 | $5,365 | 39.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 566 | 792 | $9,504 | $3,145 | 33.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $7,790 | $2,951 | 37.9% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2022 | 19 | 22 | $37,400 | $2,823 | 7.5% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 28 | 28 | $21,000 | $2,322 | 11.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $5,100 | $2,276 | 44.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 15 | 19 | $18,810 | $2,123 | 11.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $3,900 | $2,120 | 54.4% |
About Dr. Michael Stanik, MD
Dr. Michael Stanik, MD is a Specialist healthcare provider based in Prescott, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609812247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Stanik, MD has received a total of $1,222 in payments from pharmaceutical and medical device companies, with $94.83 received in 2022. These payments were reported across 116 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,124).
As a Medicare-enrolled provider, Stanik has provided services to 13,215 Medicare beneficiaries, totaling 26,438 services with total Medicare billing of $1.2M. Data is available for 3 years (2020–2022), covering 119 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Prescott, AZ
- Active Since 06/21/2006
- Last Updated 06/24/2009
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1609812247
Products in Payments
- TOVIAZ (Drug) $313.43
- VIAGRA (Drug) $179.48
- Myrbetriq (Drug) $120.30
- XTANDI (Drug) $111.50
- Erleada (Drug) $67.08
- GEMTESA (Drug) $55.04
- LUPRON DEPOT (Drug) $41.34
- REZUM (Device) $35.66
- MYRBETRIQ (Drug) $33.63
- ORGOVYX (Drug) $22.56
- SpeediCath (Device) $18.19
- Vortek (Device) $17.23
- General - Vascular Access (Device) $14.11
- SPEEDICATH (Device) $13.97
- GENTLECATH (Device) $11.82
- LYRICA (Drug) $5.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Prescott
Richard Bassett, Do, DO
Specialist — Payments: $39,882
Specialist $39,882
Dr. Shayan Alam, M.d, M.D
Specialist — Payments: $5,729
Specialist $5,729
Paul Nguyen, Md, MD
Specialist — Payments: $1,749
Specialist $1,749
Mr. Ben Paxton, M.d, M.D
Specialist — Payments: $1,742
Specialist $1,742
Donn Davis, Md, MD
Specialist — Payments: $1,148
Specialist $1,148
Jeffrey Sanwick, Md, MD
Specialist — Payments: $1,082
Specialist $1,082